Senior insider sale
EVP and Chief Medical Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$15.6K
2.09K shares
What this filing means
EISNER MARK plans to sell 2.09K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $15.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/23/2026ACC: 0001959173-26-001364
Officer· EVP and Chief Medical Officer
Since Feb 2026
2.09K
Shares to sell
$15.6K
Approx. market value
2.09K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/23/2026
2.09KTotal acquired2.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted Stock Vesting Compensation | 2.09K | — |
| Total | 2.09K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.09K
Market value
$15.6K
2/23/2026
Total
Units
2.09K
Value
$15.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/23/2026 | 2.09K | $15.6K | NASDAQ | Planned |
| Total | 2.09K | $15.6K | ||